ORGANOIDS

OC Oncoclínicas RJ

Others

Organoids as a platform for personalized medicine in oncology

Center

OC Oncoclínicas RJ

Principal investigator

Carlos Gil Moreira Ferrera

Email

carlosgil.ferreira@oncoclinicas.com

Telephone

(21) 2127-0281/82

Inclusion criteria

Participants with a diagnosis of metastatic colon or rectal cancer submitted to tumor tissue puncture/biopsy or to surgical treatment with tumor resection;

Participants diagnosed with metastatic lung cancer who have undergone either tumor tissue puncture/biopsy or surgical treatment with tumor resection;

Participants diagnosed with metastatic breast cancer who have undergone either tumor tissue puncture/biopsy or surgical treatment with tumor resection;

Participants who have failed at least one line of systemic therapy;

Availability of 1 cm3 of fresh tumor tissue obtained by puncture/biopsy or surgical resection of the tumor;

Technical feasibility of punctures/biopsies of tumor lesions located in the skin, subcutaneous tissue, lymph nodes, breast, gastrointestinal tract, airways, bones, and liver by interventional radiology or endoscopy/colonoscopy/bronchoscopy techniques.

Exclusion criteria

Participants taking antiplatelet agents, anticoagulants, or those with bleeding disorders;

Participants with preoperative anesthetic classification ASA IV, V or VI.

Coordinator(s)

Tamires Almeida
Share
Or share the link
Link copied to your desktop.